Latest News

March 11, 2014
Laura van ‘t Veer, PhD, was honored this week as one of the top female scientific innovators in Europe, winning one of the 2014 European Union Prizes for Women Innovators.
August 30, 2013
A team of researchers at UCSF is incorporating genomics into a broad group of potential factors that can help clinicians better understand which patients are at greatest risk for persistent postsurgical pain and how to better prevent or treat it.
June 13, 2013
The scientific community at UCSF is reacting positively to the Supreme Court’s unanimous ruling that human genes cannot be patented.
March 18, 2013
The American Cancer Society will pay tribute to Laura Esserman, MD, MBA, a nationally and internationally known leader in the field of breast cancer care and research, on March 19.
June 01, 2012
The U.S. Food and Drug Administration is issuing new recommendations for breast cancer trials that are based in part on groundbreaking, national breast cancer research led by UCSF.
March 26, 2012
Long considered a New Age way of meditating and exercising, yoga, qigong and tai chi have increasingly become popular among cancer patients who regain strength and balance after chemotherapy and surgery.
October 13, 2011
Triple-negative breast cancer is the most deadly form of the disease. This form of breast cancer has a disproportionate impact on women who are younger, African American or Hispanic, but new discoveries, including a new treatment approach targeting inflammation in cancer, may help women survive the disease.
September 29, 2011
A new way to study and treat breast cancer being launched at the University of California, San Francisco (UCSF) in October will screen women for the disease and provide them with individual assessments of their risk of developing the cancer.    
September 29, 2011
UCSF professor Goerge Sawaya, MD, a member of the  U.S. Preventive Services Task Force that developed updated recommendations on breast cancer screening, discusses the rationale and the role of science in advancing change in clinical practice in this video.
September 29, 2011
It’s a matter of fairness: members of all ethnic groups should have the opportunity to participate in clinical trials. And it’s a matter of soundness, too: medical advancements must be tested in as many different people with as many different genetic makeups as possible.

Pages